Triasima Portfolio Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
10,046
+3,695
+58% +$3.78M 1.63% 11
2026
Q1
$5.84M Buy
6,351
+381
+6% +$386K 0.88% 42
2025
Q4
$6.42M Buy
+5,970
New +$5.71M 0.96% 32
2025
Q1
Sell
-5,311
Closed -$4.1M 157
2024
Q4
$4.1M Buy
+5,311
New +$4.4M 0.8% 36
2024
Q3
Sell
-9,914
Closed -$8.98M 114
2024
Q2
$8.98M Sell
9,914
-31
-0.3% -$24.8K 0.82% 30
2024
Q1
$7.74M Sell
9,945
-3,182
-24% -$2.26M 0.65% 39
2023
Q4
$7.65M Sell
13,127
-1,344
-9% -$784K 0.63% 33
2023
Q3
$7.77M Sell
14,471
-745
-5% -$384K 0.71% 32
2023
Q2
$9.45M Sell
15,216
-496
-3% -$208K 0.6% 35
2023
Q1
$5.4M Sell
15,712
-17,145
-52% -$5.78M 0.45% 42
2022
Q4
$12M Buy
32,857
+10,795
+49% +$3.83M 0.92% 29
2022
Q3
$7.13M Sell
22,062
-210
-0.9% -$66.5K 0.58% 36
2022
Q2
$7.22M Buy
22,272
+2,660
+14% +$798K 0.51% 36
2022
Q1
$5.62M Buy
19,612
+577
+3% +$148K 0.27% 47
2021
Q4
$5.26M Buy
19,035
+1,575
+9% +$399K 0.25% 46
2021
Q3
$4.03M Buy
17,460
+4,760
+37% +$1.17M 0.22% 57
2021
Q2
$2.92M Buy
12,700
+4,420
+53% +$888K 0.14% 74
2021
Q1
$1.55M Hold
8,280
0.08% 107
2020
Q4
$1.4M Buy
+8,280
New +$1.24M 0.08% 97

Other funds holding LLY

Triasima Portfolio Management's LLY Position: Q2 2026 in Review

Triasima Portfolio Management increased its Eli Lilly (LLY) stake by 58% in Q2 2026, buying an estimated $3.78M and bringing the position to 10,046 shares worth $12M. The position accounts for 1.63% of the portfolio, ranked #11.

Triasima Portfolio Management first reported a position in LLY in Q4 2020 and has held it in 19 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Triasima Portfolio Management held 10,046 shares of Eli Lilly worth $12M as of Q2 2026.
  • Triasima Portfolio Management bought 3,695 Eli Lilly shares in Q2 2026, an estimated $3.78M.
  • Eli Lilly made up 1.63% of Triasima Portfolio Management's portfolio in Q2 2026, its #11 holding.
  • Triasima Portfolio Management first reported a position in Eli Lilly in Q4 2020 and has held it in 19 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Triasima Portfolio Management's 13F filing for Q2 2026, filed 21 Jul 2026.